Eli Lilly (NYSE:LLY) has already manufactured billions of doses of its next-generation weight-loss pill, anticipating strong global demand ahead of a potential launch next year. “We’ve already made, ...

Eli Lilly & Co. has already produced billions of doses of its next-generation weight-loss pill, anticipating massive global demand ahead of a potential launch next year. “We’ve already made, actually, ...

What if being cold could increase your metabolism and help you lose weight? No one likes to be cold enough to shiver, but what if being cold could actually increase your metabolism, improve blood ...

EAST PROVIDENCE, R.I. (WPRI) — A weight loss pill may become available by the end of this year or early in 2026. Dr. Ashish Jha, dean of Brown University’s School of Public Health, joined 12 News at 4 ...

On I Am Jazz, star Jazz Jennings has been honest about her struggle with mental and physical health and what finally inspired her to lose weight. Here's a candid look at her weight loss journey and ...

GLP-1 medications have been a life-changing tool to help people manage their blood sugar and lose weight. But the most popular forms of these medications have a big drawback: you have to inject ...

A pill form of the weight loss drug Wegovy was as effective as injections for people with obesity in a clinical trial, the drug's manufacturer said. Novo Nordisk said in its news release that ...

An intriguing new option is coming for weight-loss drugs: a pill that you take once a day to shed pounds, rather than the weekly injections that have powered the anti-obesity revolution up to now. The ...

This is an edition of The Future of Everything newsletter, a look at how innovation and technology are transforming the way we live, work and play. If you’re not subscribed, sign up here.

Novo Nordisk said that patients taking a pill form of Wegovy in a clinical trial lost about as much weight as those who get the shot version, fueling new optimism that oral GLP-1 drugs could expand an ...

In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that ...